| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Viking Therapeutics (NASDAQ:VKTX) through any online brokerage.
Other companies in Viking Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Viking Therapeutics has a consensus price target of $94.90.
The stock price for Viking Therapeutics (NASDAQ: VKTX) is $27.64 last updated October 13, 2026 at 10:48 AM EDT.
There are no upcoming dividends for Viking Therapeutics.
Viking Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Viking Therapeutics.
Viking Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
